New Melanoma Treatments Hit Tumors Where They Live
There's a pipeline full of new melanoma therapies that target the immune system. Monday, May 5. is Melanoma Monday.
There's a pipeline full of new melanoma therapies that target the immune system. Monday, May 5. is Melanoma Monday.
A noninvasive molecular test identifies patients more likely to respond to JAK inhibitors versus Th2-targeted therapies, potentially accelerating clearance and reducing treatment switches.